December 9, 2024 03:44 PM EST
Pharma
FDA+
Law

Supreme Court de­clines to take PhRMA-Arkansas 340B case

Zachary Brennan

Senior Editor

The US Supreme Court on Mon­day said it won’t hear a case re­lat­ed to the ex­pan­sion of the fed­er­al 340B drug …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

Sion­na and Odyssey end JPM week with IPO fil­ings

An­oth­er US biotech emerges with drug can­di­date from Chi­na-based Keymed

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times